1Department of Microbiology, Faculty of Agriculture Ain Shams University, Cairo, Egypt; 2Department of Virus and Phytoplasma, Plant disease institute, Agri. Res. center. Giza, Egypt; 3Department of Biology, Faculty of Science, Jazan University, Jazan 45142, P.O.Box:114, Saudi Arabia.
ABSTRACT
Virus-like particles (VLPs) are biological entities at the nanoscale level that are made of viral proteins organized in a morphology that resembles the original virion but lacks the viral genetic material. VLPs are appealing as a system because their proteins can be altered both chemically and genetically, opening up a wide range of potential uses. Virus-like particles (VLPs) are ideal for antigen and medication administration because viruses are strong immune activators and efficient vectors for transporting genetic elements into host cells. Recent developments in VLP platform engineering, activation, and release strategies, in addition to their application to drug administration, are discussed. The utilize of VLPs for drug delivery in model systems is discussed, and various examples of its effectiveness are highlighted.
To share on other social networks, click on any
share button. What are these?